|
|
Found results for
 patents
1.
|
Peptide conjugates of microtubule-targeting agents as therapeutics
| Application Number |
18152987 |
| Grant Number |
12234212 |
| Status |
In Force |
| Filing Date |
2023-01-11 |
| First Publication Date |
2024-02-29 |
| Grant Date |
2025-02-25 |
| Owner |
Cybrexa 3, Inc. (USA)
|
| Inventor |
- Marshall, Daniel Richard
- Csengery, Johanna Marie
- Maguire, Robert John
- Volkmann, Robert A.
|
Abstract
The present invention relates to peptide conjugates of microtubule-targeting agents such as maytansinoid derivatives which are useful for the treatment of diseases such as cancer.
IPC Classes ?
- C07D 265/12 - 1,3-OxazinesHydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
|
2.
|
PEPTIDE CONJUGATES OF THERAPEUTICS
| Application Number |
US2022012079 |
| Publication Number |
2022/155172 |
| Status |
In Force |
| Filing Date |
2022-01-12 |
| Publication Date |
2022-07-21 |
| Owner |
CYBREXA 3, INC. (USA)
|
| Inventor |
- Maguire, Robert John
- Csengery, Johanna Marie
|
Abstract
The present invention relates to conjugates of therapeutic molecules (e.g., cytotoxic agents) and targeting moieties (e.g., peptides) which are useful in the treatment of diseases such as cancer.
IPC Classes ?
- A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61P 35/00 - Antineoplastic agents
- C07K 14/215 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Halobacteriaceae (F)
|
3.
|
PEPTIDE CONJUGATES OF MICROTUBULE-TARGETING AGENTS AS THERAPEUTICS
| Application Number |
US2020041348 |
| Publication Number |
2021/007402 |
| Status |
In Force |
| Filing Date |
2020-07-09 |
| Publication Date |
2021-01-14 |
| Owner |
CYBREXA 3, INC. (USA)
|
| Inventor |
- Marshall, Daniel Richard
- Csengery, Johanna Marie
- Maguire, Robert John
- Volkmann, Robert A.
|
Abstract
The present invention relates to peptide conjugates of microtubule-targeting agents such as maytansinoid derivatives which are useful for the treatment of diseases such as cancer.
IPC Classes ?
- A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61P 35/00 - Antineoplastic agents
- C07K 14/00 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
|
4.
|
PEPTIDE CONJUGATES OF MICROTUBULE-TARGETING AGENTS AS THERAPEUTICS
| Document Number |
03146385 |
| Status |
Pending |
| Filing Date |
2020-07-09 |
| Open to Public Date |
2021-01-14 |
| Owner |
CYBREXA 3, INC. (USA)
|
| Inventor |
- Marshall, Daniel Richard
- Csengery, Johanna Marie
- Maguire, Robert John
- Volkmann, Robert A.
|
Abstract
The present invention relates to peptide conjugates of microtubule-targeting agents such as maytansinoid derivatives which are useful for the treatment of diseases such as cancer.
IPC Classes ?
- A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61P 35/00 - Antineoplastic agents
- C07K 7/08 - Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K 14/00 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
|
5.
|
Peptide conjugates of microtubule-targeting agents as therapeutics
| Application Number |
16924445 |
| Grant Number |
11555019 |
| Status |
In Force |
| Filing Date |
2020-07-09 |
| First Publication Date |
2021-01-14 |
| Grant Date |
2023-01-17 |
| Owner |
Cybrexa 3, Inc. (USA)
|
| Inventor |
- Marshall, Daniel Richard
- Csengery, Johanna Marie
- Maguire, Robert John
- Volkmann, Robert A.
|
Abstract
The present invention relates to peptide conjugates of microtubule-targeting agents such as maytansinoid derivatives which are useful for the treatment of diseases such as cancer.
IPC Classes ?
- C07D 265/12 - 1,3-OxazinesHydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
|
|
